99 related articles for article (PubMed ID: 3101609)
1. [Synergistic action of lentinan (LNT) with endocrine therapy of breast cancer in rats and humans].
Kosaka A; Kuzuoka M; Yamafuji K; Imaizumi A; Hattori Y; Yamashita A
Gan To Kagaku Ryoho; 1987 Feb; 14(2):516-22. PubMed ID: 3101609
[TBL] [Abstract][Full Text] [Related]
2. [Cumulative effects of lentinan and endocrine therapy on the growth of DMBA-induced mammary tumor in rats].
Kosaka A; Imaizumi A; Hatori Y; Mori F; Wani T; Yamashita A
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1399-407. PubMed ID: 6430243
[TBL] [Abstract][Full Text] [Related]
3. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].
Taguchi T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):387-93. PubMed ID: 6349538
[TBL] [Abstract][Full Text] [Related]
4. [Ultrastructural study of rat mammary tumors and human breast cancer cells following treatment with tamoxifen].
Kamioki S
Gan No Rinsho; 1986 Nov; 32(14):1809-18. PubMed ID: 3099030
[TBL] [Abstract][Full Text] [Related]
5. [Experimental studies on the enhanced effects of chemoendocrine therapy in breast cancer].
Abe R; Sawano A; Ueki H; Akimoto M; Kimura M
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):785-92. PubMed ID: 3566291
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
[TBL] [Abstract][Full Text] [Related]
7. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz(alpha)anthracene-induced rat mammary carcinomas.
Weckbecker G; Tolcsvai L; Stolz B; Pollak M; Bruns C
Cancer Res; 1994 Dec; 54(24):6334-7. PubMed ID: 7987824
[TBL] [Abstract][Full Text] [Related]
8. [Effect of lentinan administration of adrenalectomized rats and patients with breast cancer].
Kosaka A; Wani T; Hattori Y; Yamashita A
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1474-81. PubMed ID: 6764117
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of lentinan on patients with stomach cancer: end point results of a four-year follow-up survey.
Taguchi T
Cancer Detect Prev Suppl; 1987; 1():333-49. PubMed ID: 3121179
[TBL] [Abstract][Full Text] [Related]
10. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
11. [Changes of hormone receptor status in various treatment for human breast cancer and DMBA tumor of the rat].
Iino Y; Yamazaki K; Ishikawa H; Endo K; Arai T; Ogawa T; Hoshino K; Ishida T; Yokoe T; Takahashi T
Gan No Rinsho; 1984 Oct; 30(13):1633-7. PubMed ID: 6239934
[TBL] [Abstract][Full Text] [Related]
12. [Effect of tamoxifen plus octreotide on DMBA-induced mammary tumors in rats].
Zeng XZ; Yao ZX
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):28-32. PubMed ID: 15808071
[TBL] [Abstract][Full Text] [Related]
13. Effects of alterations in early hormonal environment on development and hormone dependency of carcinogen-induced mammary tumors in rats.
Sylvester PW; Aylsworth CF; Van Vugt DA; Meites J
Cancer Res; 1983 Nov; 43(11):5342-6. PubMed ID: 6413057
[TBL] [Abstract][Full Text] [Related]
14. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
15. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
[TBL] [Abstract][Full Text] [Related]
16. [Effects of chemo-endocrine therapy on DMBA-induced rat mammary carcinoma].
Yamamoto H; Morimoto T; Monden A
Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1786-92. PubMed ID: 2512479
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of the thymosin immunoregulatory effect by hypocorticoidism in rats with DMBA-induced carcinogenesis in mammary glands.
Grinevich YuA ; Kamenets LYa
Neoplasma; 1982; 29(1):19-27. PubMed ID: 6803177
[TBL] [Abstract][Full Text] [Related]
18. Comparison of ovariectomy and retinyl acetate on the growth of established 7,12-dimethylbenz[a]anthracene-induced mammary tumors in the rat.
Gandilhon P; Melancon R; Djiane J; Kelly PA
J Natl Cancer Inst; 1982 Aug; 69(2):447-51. PubMed ID: 6287078
[TBL] [Abstract][Full Text] [Related]
19. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
[TBL] [Abstract][Full Text] [Related]
20. Antiestrogen treatment of breast cancer: an overview.
Pearson OH; Manni A; Arafah BM
Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
